Company Protagonist Therapeutics Inc Nasdaq
Equities
US74366E1029
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- PTS | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Peptide-based Therapeutics
100.0
%
| 27 | 100.0 % | 60 | 100.0 % | +125.73% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 27 | 100.0 % | 60 | 100.0 % | +125.73% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01/08/01 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 18/22/18 |
Chief Tech/Sci/R&D Officer | - | 01/17/01 | |
Samuel Saks
CTO | Chief Tech/Sci/R&D Officer | 69 | 24/18/24 |
Arturo Molina
CTO | Chief Tech/Sci/R&D Officer | 65 | 07/22/07 |
Craig Ostroff
LAW | General Counsel | - | - |
Carena Spivey
HRO | Human Resources Officer | - | - |
Suneel Gupta
PRN | Corporate Officer/Principal | 66 | 17/19/17 |
Ashok Bhandari
PRN | Corporate Officer/Principal | - | 01/17/01 |
Carter J. King
PRN | Corporate Officer/Principal | 52 | 01/18/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 08/17/08 |
Harold Selick
CHM | Chairman | 69 | 01/09/01 |
Daniel Swisher
BRD | Director/Board Member | 61 | 26/23/26 |
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01/08/01 |
Sarah O'Dowd
BRD | Director/Board Member | 74 | 12/20/12 |
William Waddill
BRD | Director/Board Member | 67 | 01/16/01 |
Bryan Giraudo
BRD | Director/Board Member | 48 | 16/18/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 58,652,133 | 57,477,120 ( 98.00 %) | 0 | 98.00 % |
Company contact information
Protagonist Therapeutics, Inc.
7707 Gateway Boulevard Suite 140
94560-1160, Newark
+
http://www.protagonist-inc.comSector
1st Jan change | Capi. | |
---|---|---|
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+43.45% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- PTGX Stock
- Stock
- Company Protagonist Therapeutics Inc